NASDAQ Composite: ( -0.71%) 17 733

S&P 500 Futures
(0.16%) 5 530.50 points

Dow Jones Futures
(0.15%) 39 527 points

Nasdaq Futures
(0.17%) 19 962 points

Oil
(0.76%) $82.16

Gas
(-1.00%) $2.58

Gold
(-0.23%) $2 334.30

Silver
(-0.24%) $29.49

Platinum
(0.33%) $1 005.20

USD/EUR
(-0.50%) $0.928

USD/NOK
(-0.59%) $10.61

USD/GBP
(-0.24%) $0.789

USD/RUB
(1.64%) $87.13

Sanntidsoppdatering for Sarepta Therapeutics, [0L35.L]

Børs: London Stock Exchange Sektor: Healthcare Industri: Medical - Pharmaceuticals

Sist oppdatert28 jun 2024 @ 19:55

25% discount on Stockinvest.us - Use code: Podcast

1.37% $ 158.65

Live Chart Being Loaded With Signals

Commentary (28 jun 2024 @ 19:55):
Our systems believe the stock currently is overvalued by -1.25% compare to its pairs and should correct downwards.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases...

Stats
Dagens volum	351
Gjennomsnittsvolum	424
Markedsverdi	15.00B
EPS	$0.380 ( Q1 \| 2024-05-01 )
Neste inntjeningsdato	( $0 ) 2024-07-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-37.02 (Sector) 0 (Industry) 0
ATR14	$1.006 (0.64%)